Last Checked: October 5, 2026Next Check: October 5, 2027
- trumprx.govcited ×1216 reviewed
- whitehouse.govcited ×3
- fda.govcited ×2
- cms.govcited ×1
- medicare.govcited ×1
- kff.orgcited ×11
- citizen.orgcited ×3
- healthsystemtracker.orgcited ×3
Last updated 1 week ago. Our resources are updated regularly but please keep in mind that links, programs, policies, and contact information do change.
TrumpRx is a government-operated website where people can search for discounted prices on brand-name medicines when paying without using insurance. It advertises Plavix for $15.95 with a 98 percent discount. On the Plavix product page, it tells insured patients to check their copay first; it may be lower. The discount compares the offer with a manufacturer’s list price, not with the patient’s own price.
The table below lists the offers the site labels ‘Presidential deals,’ with the cash offer, list price and advertised discount shown on September 25, 2026. For any medicine in the catalog, the useful question is what the exact prescription would cost through each available route.
What the advertised discount measures
KFF, the health policy research group, explains that the site’s advertised savings use the manufacturer’s wholesale list price as the reference. That list price typically does not reflect what an insured consumer would have paid. A 90 percent discount can be substantial without being a 90 percent reduction in a particular family’s spending.
A TrumpRx product page describes its amount as an out-of-pocket price and asks the visitor to select a form, strength and quantity. For Protonix, the page changes the configuration across tablet or packet form, strength and pill count. The catalog’s ‘starting at’ number is an entry point; a selected prescription can produce a different offer. A meaningful comparison uses the same drug, form, strength and amount on both sides.
TrumpRx itself warns insured visitors that their copay may be lower than the displayed cash price. In KFF’s review published on February 24, 2026, about half of the listed drugs had generic equivalents, and at least three-quarters of those generics cost less through other cash-price routes than the TrumpRx coupon price for the brand. That review did not cover every medicine in the table below, but it shows why the brand-name offer should not end the search.
A patient should ask the pharmacist or prescriber whether an appropriate generic exists before switching a prescribed product. The Food and Drug Administration (FDA) advises people to discuss generic medicines with a doctor, pharmacist or other health care provider.
Every listing in the Presidential Deals catalog
The official browse page calls this group ‘Presidential deals,’ describes them as deals negotiated by President Trump for brand-name drugs and displayed 80 catalog listings when checked. The table below records that check, made on September 25, 2026, and is not a live price list. Offers and discounts vary widely: Humira Pen was listed at $950.00, while Relenza was listed at $52.90 against $59.00.
| Medicine | Cash offer | List price | Advertised discount |
|---|---|---|---|
| Plavix® | $15.95 | $771.62 | 98 percent |
| Combigan® | $10.00 | $204.13 | 95 percent |
| Mayzent® | From $41.23 | $623.00 | 93 percent |
| Cetrotide® | $22.50 | $316.12 | 93 percent |
| Xigduo® XR | From $45.00 | $599.72 | 92 percent |
| Toujeo® | From $35.00 | $428.57 | 92 percent |
| Farxiga® | From $35.00 | $377.82 | 91 percent |
| Zeposia® | From $925.00 | $9,060.76 | 90 percent |
| Sotyktu® | $743.00 | $7,135.55 | 90 percent |
| Jentadueto® | From $55.00 | $525.08 | 90 percent |
| Jentadueto® XR | From $55.00 | $525.08 | 90 percent |
| Wegovy® Pill | From $149.00 | $1,349.02 | 89 percent |
| Bevespi® | $50.65 | $458.05 | 89 percent |
| Striverdi® Respimat® | $35.00 | $276.00 | 87 percent |
| Humira® Pen | $950.00 | $6,922.62 | 86 percent |
| Humira® Prefilled Syringe | From $950.00 | $6,922.62 | 86 percent |
| Ozempic® Pill | From $149.00 | $1,027.51 | 85 percent |
| Wegovy® Pen | From $199.00 | $1,349.02 | 74 percent to 85 percent |
| Duavee® | $30.30 | $202.00 | 85 percent |
| Toviaz® | From $43.50 | $290.00 | 85 percent |
| Lovenox® | From $11.90 | $74.42 | 84 percent |
| Gonal-F® | From $168.00 | $966.04 | 83 percent |
| Ozempic® Pen | From $199.00 | $1,027.51 | 66 percent to 81 percent |
| Eucrisa® | $158.48 | $792.40 | 80 percent |
| Amjevita® | $299.00 | $1,484.16 | 80 percent |
| Rydapt® | From $2,908.64 | $13,411.00 | 78 percent |
| Tabrecta® | From $2,649.92 | $11,666.00 | 77 percent |
| Foundayo™ | From $149.00 | $649.00 | 77 percent |
| Alphagan® P | $45.00 | $194.44 | 77 percent |
| Janumet® | From $84.57 | $330.00 | 74 percent |
| Janumet® XR | From $84.57 | $330.00 | 74 percent |
| Januvia® | From $84.57 | $330.00 | 74 percent |
| Zepbound® Vial | From $299.00 | $1,087.00 | 72 percent |
| Insulin Glargine (U-300) | From $35.00 | $126.33 | 72 percent |
| Xofluza® | From $50.00 | $168.83 | 70 percent |
| Airsupra® | $156.63 | $503.93 | 69 percent |
| Xarelto® | From $197.00 | $611.82 | 68 percent |
| Ovidrel® | $84.00 | $251.84 | 67 percent |
| Admelog® | From $35.00 | $98.07 | 64 percent |
| Synthroid® | From $18.75 | $52.11 | 64 percent |
| Enbrel® | $3,353.93 | $9,177.30 | 63 percent |
| Tresiba® | From $35.00 | $94.29 | 63 percent |
| Invokamet® | From $225.00 | $598.56 | 62 percent |
| Invokamet® XR | From $225.00 | $598.56 | 62 percent |
| Invokana® | From $225.00 | $598.56 | 62 percent |
| Aimovig® | From $299.00 | $783.02 | 62 percent |
| Repatha® | $239.00 | $625.89 | 62 percent |
| Prempro® | From $98.84 | $254.30 | 61 percent |
| Trulicity® | From $389.00 | $987.19 | 61 percent |
| Abrilada® | From $207.60 | $519.00 | 60 percent |
| Genotropin® | From $89.67 | $224.14 | 60 percent |
| Emgality® | $299.00 | $741.69 | 60 percent |
| Apidra® | From $35.00 | $85.19 | 59 percent |
| Praluent® | From $225.00 | $537.21 | 58 percent |
| Mounjaro® | From $499.00 | $1,112.16 | 55 percent |
| Incruse® Ellipta | $159.20 | $354.10 | 55 percent |
| Premarin® | From $99.00 | $217.86 | 55 percent |
| Pristiq® | From $200.10 | $435.00 | 54 percent |
| NovoLog® | From $35.00 | $72.34 | 52 percent |
| NovoLog® Mix 70/30 | From $35.00 | $72.34 | 52 percent |
| Fiasp® | From $35.00 | $71.66 | 51 percent |
| Arnuity® Ellipta | From $102.98 | $208.49 | 51 percent |
| Colestid® | From $67.20 | $135.60 | 50 percent |
| Ngenla® | From $2,217.00 | $4,434.20 | 50 percent |
| Azulfidine® | From $99.60 | $199.20 | 50 percent |
| Azulfidine® EN-tabs | From $130.80 | $261.60 | 50 percent |
| Premarin® Vaginal Cream | $236.65 | $473.30 | 50 percent |
| Vfend® | $306.98 | $613.96 | 50 percent |
| Viracept® | From $607.20 | $1,214.40 | 50 percent |
| Zyvox® | $122.74 | $245.48 | 50 percent |
| Zavzpret® | $594.84 | $1,189.65 | 50 percent |
| Merilog™ | From $35.00 | $69.57 | 50 percent |
| Anoro® Ellipta | $247.94 | $489.09 | 49 percent |
| Lantus® | From $35.00 | $64.26 | 46 percent |
| Zepbound® KwikPen® | From $299.00 | $499.00 | 40 percent |
| Otezla® | $3,353.93 | $5,589.89 | 40 percent |
| Orencia® SC | From $3,660.00 | $6,070.59 | 40 percent |
| Xeljanz® | From $1,518.00 | $2,277.43 | 33 percent |
| Priftin® | $93.30 | $121.55 | 23 percent |
| Relenza® | $52.90 | $59.00 | 10 percent |
| Insulin Lispro | From $25.00 | Not shown | Not shown |
In that check, the browse page listed Insulin Lispro starting at $25.00 and displayed no comparison price or discount percentage. A blank comparison field is not a zero discount; the site simply does not make that comparison on the card. Some catalog cards advertise a discount range, including the Wegovy pen and Ozempic pen. Open the product page and choose the actual prescription before treating any row as a quote.
Getting a deal from the screen to the pharmacy
TrumpRx functions as a search portal for discounted self-pay offers rather than a pharmacy that sells the medicines itself. For most of the medicines KFF examined, the site directed users to print a manufacturer coupon for use at a retail pharmacy. The route may look different for a drug handled through the manufacturer’s own direct-order channel. In either case, the catalog price is not a prescription or a guarantee that a pharmacy will have the product.
A valid prescription is required to buy every listed medicine. On a product page such as Protonix, visitors choose the form, strength and quantity before seeing the offer. The same page presents a coupon to show at a participating retail pharmacy. For Protonix, the official page says its coupon is widely supported at retail pharmacies that dispense the drug. A patient should confirm both the exact product and the final checkout price before paying.
Public Citizen, an advocacy group that argues the deals favor drug companies over patients, reviewed the released agreements and found that Pfizer and Eli Lilly did not write identical terms for patients in federal health programs. It says Pfizer’s disclosed text does not obligate it to offer covered products to people enrolled in a federal health care program through a platform that sells directly to patients.
The review says Lilly’s cash-price commitment for GLP-1 drugs, by contrast, covers patients regardless of insurance status, including government insurance. FDA describes GLP-1 receptor agonists as medicines used for type 2 diabetes or for weight loss in people with obesity or overweight. Eligibility for one manufacturer’s offer should not be assumed from another manufacturer’s card. Patients with Medicare or Medicaid should read the particular offer’s terms rather than assume the federal program will pay a TrumpRx transaction.
Insurance changes the comparison
KFF describes TrumpRx manufacturer coupons as self-pay transactions rather than purchases billed to private insurance. KFF says spending on such a coupon does not count toward a private plan’s deductible or out-of-pocket maximum. Money that counts toward a deductible can reduce what a patient owes for later covered care; by KFF’s account, money spent on a TrumpRx coupon does not count.
Part D is Medicare’s prescription-drug coverage. Medicare’s comparison tools let a person with Medicare enter prescription drugs and estimate monthly and annual plan costs. Medicare also has negotiated prices of its own: the Centers for Medicare and Medicaid Services (CMS) negotiated prices for selected Part D drugs that took effect on January 1, 2026. For a person with Part D, what matters is what the plan would charge for the drug compared with the cash offer, not which program advertises the bigger discount.
KFF reports that private insurers’ negotiated prices are often lower than the wholesale list price used in TrumpRx’s percentage calculation. KFF also notes that a discounted self-pay price may help an insured person who otherwise faces a high payment before meeting a deductible. The patient’s copay, deductible position, and any generic option have to be checked together.
What the government negotiated
The White House says President Donald Trump launched TrumpRx.gov on February 5, 2026. The administration says President Trump has announced deals with major pharmaceutical manufacturers to bring prices in line with those paid in other developed nations. The Peterson-KFF Health System Tracker is a collaboration between KFF and the Peterson Center on Healthcare that monitors U.S. healthcare quality and cost. A Peterson-KFF Health System Tracker analysis says the manufacturers whose drugs were on the site at launch had signed voluntary agreements with the White House, typically in exchange for tariff exemptions.
In an August 31, 2026 fact sheet, the White House claimed patients had saved more than $700 million through TrumpRx since its launch. That is the administration’s aggregate claim, not an estimate of what any one reader can save.
The Peterson-KFF analysis notes that questions have been raised about whether TrumpRx prices are lower than drug prices in other countries, as the website states. Its comparison found TrumpRx to be the lowest among peer-country prices for five of the 32 brand-name drugs it could compare.
Public Citizen’s review of released deal documents says Pfizer’s disclosed agreement ends on Jan. 20, 2029. The same review says the publicly released Lilly agreement redacts its termination provision. Public Citizen argues that redactions in the disclosed agreements obscure important prices and eligibility terms. The released documents do not establish when every catalog offer expires, so check the live offer terms to know whether a price still exists.
Before filling the prescription
The live TrumpRx site lets a visitor search the current brand-name offers and follow the listed coupon or manufacturer route. Check the exact strength and quantity on TrumpRx. If insured, compare the immediate cash price with the copay, any suitable generic, and how a self-pay fill would affect spending over the plan year.
Medicare’s own tools offer plan-cost estimates and links to pharmaceutical assistance programs for people with Medicare. Medicare says people meeting its income and resource limits may qualify for Extra Help with drug-coverage premiums, deductibles and copays. For Medicare or Medicaid coverage, ask the plan and the offer program how that particular purchase will be handled.
